Article Text

Download PDFPDF
Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy
  1. Ahmed Rashed1,
  2. Sekon Won2,
  3. Marwan Saad3,
  4. Theodore Schreiber4
  1. 1DMC/Wayne State University, Detroit, Michigan, USA
  2. 2DMC/Cardiovascular Institute Harper University Hospital, Detroit, Michigan, USA
  3. 3Department of Internal Medicine, TRMC/Seton Hall University School of Medicine and Health Sciences, Elizabeth, New Jersey, USA
  4. 4Department of Cardiovascular Medicine, DMC/Cardiovascular institute, Harper University Hospital, Detroit, Michigan, USA
  1. Correspondence to Dr Ahmed Rashed, dr.a.rashed{at}


We report a case of cardiogenic shock, believed to be secondary to stress-induced cardiomyopathy, managed by an Impella 2.5 assist device. Apical ballooning pattern was evident on left ventriculogram with no significant coronary artery disease on coronary angiography. Cardiogenic shock was initially managed medically with inotropes and vasopressors, but because the patient was clinically deteriorating, an Impella 2.5 left ventricular assist device was implanted. Remarkable recovery occurred within 48 h of implantation with significant increase in ejection fraction and only minimal residual apical hypokinesis observed on repeat ventriculogram.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.